Form 4: ChromaDex Corp. Director Shahbazi Acquires 20,000 Stock Options

Director Hamed Shahbazi reports acquisition of 20,000 ChromaDex Corp. stock options exercisable at $2.71, vesting on June 20, 2025.

Summary

• Hamed Shahbazi, a director of ChromaDex Corp., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on June 20, 2024.
• Shahbazi acquired 20,000 stock options with an exercise price of $2.71.
• The options vest 100% on June 20, 2025, and expire on June 19, 2034.
• Following the transaction, Shahbazi directly owns 20,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a director's acquisition of stock options. While option grants can be seen as a positive incentive, the filing itself doesn't inherently convey strong positive or negative sentiment.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of stock options by a director could potentially signal confidence to shareholders.

Key Dates